Proteomics International Laboratories Ltd
ASX:PIQ
Proteomics International Laboratories Ltd
ASX:PIQ
Price:
1.06 AUD
1.92%
Market Closed
Updated:
May 14, 2024
P/S
Price to Sales
Price to Sales
89.7
Current
73.6
Median
4
Industry
Higher
than median
Higher
than industry value
Price to Sales (P/S) ratio is a valuation multiple that compares a company’s market capitalization to its revenues. It is an indicator of the value that financial markets have placed on each dollar of a company’s sales.
P/S
=89.7
Market Cap
/
129.7m
Revenue
1.4m
All Countries
| Market Cap | P/S | ||||
|---|---|---|---|---|---|
| AU |
|
Proteomics International Laboratories Ltd
ASX:PIQ
|
129.7m AUD | 89.7 | |
| US |
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
229.7B USD | 5.3 | |
| US |
|
Danaher Corp
NYSE:DHR
|
189.8B USD | 4.3 | |
| US |
|
Agilent Technologies Inc
NYSE:A
|
44.2B USD | 6.5 | |
| US |
|
IQVIA Holdings Inc
NYSE:IQV
|
41.9B USD | 2.8 | |
| CH |
|
Lonza Group AG
SIX:LONN
|
36.7B CHF | 5.5 | |
| KR |
|
Samsung Biologics Co Ltd
KRX:207940
|
55.6T KRW | 15 | |
| US |
|
Mettler-Toledo International Inc
NYSE:MTD
|
31.8B USD | 8.4 | |
| US |
|
West Pharmaceutical Services Inc
NYSE:WST
|
26.2B USD | 8.9 | |
| IE |
|
ICON PLC
NASDAQ:ICLR
|
25.9B USD | 3.1 | |
| US |
|
Waters Corp
NYSE:WAT
|
21.2B USD | 7.3 |
P/S Forward Multiples
Forward P/S multiple is a version of the P/S ratio that uses forecasted revenue for the P/S calculation. 1-Year, 2-Years, and 3-Years forwards use revenue forecasts for 1, 2, and 3 years ahead, respectively.
1-Year Forward
P/S
13.4
2-Years Forward
P/S
8.4
3-Years Forward
P/S
8.6
You don't have any saved screeners yet
